Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis
about
Progress towards gene therapy for cystic fibrosisTaking stock of gene therapy for cystic fibrosis"Bronchial artery delivery of viral vectors for gene delivery in cystic fibrosis; superior to airway delivery?".Gene therapy: light is finally in the tunnelPreparation of dry powder dispersions for non-viral gene delivery by freeze-drying and spray-drying.Membrane fusion plays an important role in gene transfection mediated by cationic liposomes.Targeted gene delivery to human airway epithelial cells with synthetic vectors incorporating novel targeting peptides selected by phage display.Lipoplexes and tumours. A review.The role of the toxicologic pathologist in the preclinical safety evaluation of biotechnology-derived pharmaceuticals.Current status of gene therapy for cystic fibrosis pulmonary disease.The role of CpG in DNA vaccines.Cationic lipid-mediated transfection in vitro and in vivo (review).The challenge of gene therapy and DNA delivery.Vehicles for oligonucleotide delivery to tumours.Cytotoxicity issues pertinent to lipoplex-mediated gene therapy in-vivo.Electroporation-mediated delivery of a naked DNA plasmid expressing VEGF to the porcine heart enhances protein expression.Targeting the cell cycle machinery for the treatment of cardiovascular disease.Emerging drug treatments for cystic fibrosis.Toward the pharmacogenomics of cystic fibrosis--an update.Gene transfer by guanidinium-cholesterol cationic lipids into airway epithelial cells in vitro and in vivoGene therapy via inducible nitric oxide synthase: a tool for the treatment of a diverse range of pathological conditions.Electron spin resonance spectroscopy in drug delivery.Targeted gene delivery to the lung.Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects.Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis.Limitations of the murine nose in the development of nonviral airway gene transfer.Current status of gene therapy in gastroenterology.Strategies in early clinical development for the treatment of basic defects of cystic fibrosis.Genetic medicines for CF: Hype versus reality.Sensitivity of chloride efflux vs. transepithelial measurements in mixed CF and normal airway epithelial cell populations.Ex vivo magnetofection with magnetic nanoparticles: a novel platform for nonviral tissue engineering.New perspectives in nanotherapeutics for chronic respiratory diseases.In vitro transfection of plasmid DNA by cationized gelatin prepared from different amine compounds.Using magnetic forces to enhance non-viral gene transfer to airway epithelium in vivo.Towards gene therapy for cystic fibrosis.The challenge of fetal gene therapy.Potential difference measurements in the lower airway of children with and without cystic fibrosis.Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors.In vitro and in vivo transfection of plasmid DNA in the Dunning prostate tumor R3327-AT1 is enhanced by focused ultrasound.Enhanced gene delivery to human airway epithelial cells using an integrin-targeting lipoplex.
P2860
Q22306014-E6656636-DB40-4220-A142-BEB3BBDB0D99Q24791317-E3803746-59A6-430D-8A2A-32AB96525EA0Q24807085-FDCA4B31-E54B-4350-8C82-4DC42B1722CBQ27000091-8F2A24AA-F1F0-499D-A06D-B4249DE5CE05Q30837591-7BDA26A0-8280-496E-9356-C505438E03B9Q32021050-FAF2EF4A-0EBF-4A7A-A3FF-8F845D0F187DQ33208315-A84A2942-C828-4B9C-BA45-DB0EDB792C85Q33723073-8E7DDA51-A608-415D-AEA2-ED436EB6AFC6Q33788813-F7BFFB8F-7587-4471-9B57-38546A797378Q33975113-C275637B-4238-4843-96FB-52CC1389CA81Q34005441-3D2F124A-678B-4D2D-889C-4691995D105BQ34313548-5F63F3BF-BDD4-4E4D-9DC0-B5CD7F3B5497Q34385675-F247E523-0A3D-4174-8930-BCCE6F21FE24Q34518719-74F9B2DF-8A59-4891-8349-9F4BF6A79BA3Q34634385-9BC3E389-9238-4027-B70B-24B927242B4AQ35110751-F11BF608-A9E6-499C-89BF-440EE930872FQ35164884-925DF7E5-1DC9-41BB-858A-DE923469FC89Q35602683-3B565A12-BBA0-433A-9A0F-4EDF3141C4B2Q35911156-100368A2-DB7A-4C23-8210-2976CAE13D78Q36018924-15A2B81A-98C8-4B9A-98B6-2BBB61D67D43Q37222788-2D745894-0EE1-4234-81C3-1B36C0260510Q37352715-D86323D4-8A83-423F-B2B0-BA0D18AC653FQ37486747-7960ECFB-93D1-42C0-B504-64D88563453BQ37526991-377E943D-5185-437E-ABBC-00556CB67EE6Q37616952-2DA3F666-B59D-4CAB-8F1C-371236901009Q38449399-059E5E2C-DE6E-482C-822A-158668C559CDQ38634850-7648B81E-8DFD-4BB3-B888-CB1FAC8CA826Q38733938-8F3027CC-5CD3-4216-9776-B8EED0F93A7BQ38818339-8478BA61-9071-4C72-BD56-8FB0614A3D26Q39271144-502FED39-2726-4465-B075-442105AA1B0FQ40024210-C4D8912D-333E-4160-9AE4-2F9572D60051Q40039105-2B39D376-7BD9-4CFF-999B-A1DE63EFEF19Q40246487-3B27C149-35D2-4B64-B3B6-50DC4D11F9E2Q40273201-B93A7D1D-1824-44D7-9D5D-2136D689C2BDQ40379148-2D23FA3C-3700-42CA-8600-D1313321268CQ40429935-33D0E168-A5B6-4ADD-B930-0DAB960A973DQ40455987-CF7EF481-8F87-49B5-BED3-69E633827F39Q40693497-4C3C9849-C02A-49EA-8608-56F91410BDE1Q40746476-7C58E841-F57B-4DDC-856E-E7B91BDBF9F9Q40810576-16231CBD-A03A-48A7-940E-0D556FF3A8E8
P2860
Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis
description
article
@en
im Januar 1995 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 1995
@uk
name
Liposome-mediated CFTR gene tr ...... patients with cystic fibrosis
@en
Liposome-mediated CFTR gene tr ...... patients with cystic fibrosis
@nl
type
label
Liposome-mediated CFTR gene tr ...... patients with cystic fibrosis
@en
Liposome-mediated CFTR gene tr ...... patients with cystic fibrosis
@nl
prefLabel
Liposome-mediated CFTR gene tr ...... patients with cystic fibrosis
@en
Liposome-mediated CFTR gene tr ...... patients with cystic fibrosis
@nl
P2093
P356
P1433
P1476
Liposome-mediated CFTR gene tr ...... patients with cystic fibrosis
@en
P2093
B J Stevenson
C Coutelle
M E Hodson
P G Middleton
P K Jeffery
S R Durham
P2888
P356
10.1038/NM0195-39
P407
P577
1995-01-01T00:00:00Z